Follow
Lekshmi G Kumar
Lekshmi G Kumar
Amrita Centre for Nanosciences and Molecular medicine
Verified email at aims.amrita.edu
Title
Cited by
Cited by
Year
Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells
S Maya, LG Kumar, B Sarmento, NS Rejinold, D Menon, SV Nair, ...
Carbohydrate polymers 93 (2), 661-669, 2013
1272013
Enhanced oral bioavailability and antitumor therapeutic efficacy of sorafenib administered in core–shell protein nanoparticle
L Gopakumar, M Sreeranganathan, S Chappan, S James, GS Gowd, ...
Drug Delivery and Translational Research 12 (11), 2824-2837, 2022
152022
Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and …
AR Melge, LG Kumar, K Pavithran, SV Nair, K Manzoor
Journal of Biomolecular Structure and Dynamics, 2019
122019
Self-assembled Human Serum Protein-based Core-shell Nanoparticles to Inhibit Key Oncogenic Signaling in Drug-Resistant Leukemia
AP Retnakumary, LG Kumar, N Sidharthan, P Keechilat, GL Malarvizhi, ...
Precision Nanomedicine, 1348-1364, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–4